ArticlePathology oncology research : POR2018

TIMP3 Promoter Methylation Represents an Epigenetic Marker of BRCA1ness Breast Cancer Tumours.

Ivana Maleva Kostovska et al.PubMed ↗Publisher ↗

No numbers read from the abstract.